Pharmarise Holdings (TSE:2796) PE Ratio: 50.99 (As of Jul. 21, 2026) — 129% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:2796 Pharmarise Holdings Corp TSE:2796
50 GF Score
Price 円491.00
GF Value 円608.01
Valuation Modestly Undervalued
! 10 Warning Signs
View Full Analysis

What is Pharmarise Holdings PE Ratio?

Pharmarise Holdings TSE:2796 -0.61% 50 PE Ratio is 50.99 as of Jul. 21, 2026, which is 129% above its 10-year median of 22.29. GuruFocus rates TSE:2796 with a GF Score™ of 50/100 and a GF Value™ of 円608.01 (Modestly Undervalued). The stock has 10 warning signs investors should review.

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-07-21), Pharmarise Holdings's share price is 円491.00. Pharmarise Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in May. 2026 was 円9.63. Therefore, Pharmarise Holdings's PE Ratio for today is 50.99.

Warning Sign:

Pharmarise Holdings Corp stock PE Ratio (=49.35) is close to 5-year high of 50.05.

During the past 13 years, Pharmarise Holdings's highest PE Ratio was 884.34. The lowest was 11.82. And the median was 22.29.

Pharmarise Holdings's EPS (Diluted) for the six months ended in May. 2026 was 円0.26. Its EPS (Diluted) for the trailing twelve months (TTM) ended in May. 2026 was 円9.63.

As of today (2026-07-21), Pharmarise Holdings's share price is 円491.00. Pharmarise Holdings's EPS without NRI for the trailing twelve months (TTM) ended in May. 2026 was 円7.04. Therefore, Pharmarise Holdings's PE Ratio without NRI ratio for today is 69.77.

During the past 13 years, Pharmarise Holdings's highest PE Ratio without NRI was 70.20. The lowest was 10.52. And the median was 22.14.

Pharmarise Holdings's EPS without NRI for the six months ended in May. 2026 was 円0.26. Its EPS without NRI for the trailing twelve months (TTM) ended in May. 2026 was 円7.04.

During the past 3 years, the average EPS without NRI Growth Rate was -42.80% per year.

During the past 13 years, Pharmarise Holdings's highest 3-Year average EPS without NRI Growth Rate was 67.50% per year. The lowest was -44.90% per year. And the median was -9.10% per year.

Pharmarise Holdings's EPS (Basic) for the six months ended in May. 2026 was 円0.26. Its EPS (Basic) for the trailing twelve months (TTM) ended in May. 2026 was 円10.01.

Back to Basics: PE Ratio


Pharmarise Holdings  (TSE:2796) PE Ratio Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratios are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.

PE Ratio can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio.


Pharmarise Holdings PE Ratio Related Terms


Pharmarise Holdings PE Ratio Historical Data

* Premium members only.

The historical data trend for Pharmarise Holdings's PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmarise Holdings PE Ratio Chart

Pharmarise Holdings Annual Data
Trend May17 May18 May19 May20 May21 May22 May23 May24 May25 May26
PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.06 22.72 At Loss At Loss 50.55

Pharmarise Holdings Semi-Annual Data
Nov16 May17 Nov17 May18 Nov18 May19 Nov19 May20 Nov20 May21 Nov21 May22 Nov22 May23 Nov23 May24 Nov24 May25 Nov25 May26
PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only At Loss At Loss At Loss At Loss 50.55

Pharmarise Holdings PE Ratio Competitor Comparison

For the Pharmaceutical Retailers subindustry, Pharmarise Holdings's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmarise Holdings PE Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pharmarise Holdings's PE Ratio distribution charts can be found below:

* The bar in red indicates where Pharmarise Holdings's PE Ratio falls into.


TSE:2796
50GF Score
Pharmarise Holdings Corp TSE:2796
PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pharmarise Holdings PE Ratio Calculation

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Pharmarise Holdings's PE Ratio for today is calculated as

PE Ratio=Share Price/Earnings per Share (Diluted) (TTM)
=491.00/9.630
=50.99

Pharmarise Holdings's Share Price of today is 円491.00.
For company reported semi-annually, Pharmarise Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in May. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円9.63.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:


There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Frequently Asked Questions Learn more about PE Ratio →
What does a PE Ratio of 50.99 mean?
Pharmarise Holdings (TSE:2796) has a PE Ratio of 50.99 as of Jul. 21, 2026. P/E ratio is the ratio of share price to a company's earnings per share. View historical data on Pharmarise Holdings and its competitors. This is 129% above median its historical median of 22.29. Over the past decade, Pharmarise Holdings' PE Ratio has ranged from 11.82 to 884.34.
Is Pharmarise Holdings' PE Ratio too high?
Pharmarise Holdings' current PE Ratio of 50.99 is 129% above median its 10-year median of 22.29. Over the past 10 years, this metric has ranged from a low of 11.82 to a high of 884.34. Overall, Pharmarise Holdings has a GF Score™ of 50/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pharmarise Holdings' PE Ratio compare to competitors?
Pharmarise Holdings' PE Ratio of 50.99 can be compared against companies in the Healthcare Providers & Services industry. Historically, Pharmarise Holdings' own PE Ratio has ranged from 11.82 to 884.34 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio for a Healthcare Providers & Services company?
A good PE Ratio depends on the Healthcare Providers & Services industry context. However, PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio mean?
A high PE Ratio can signal that a stock is expensive relative to its fundamentals. P/E ratio is the ratio of share price to a company's earnings per share. View historical data on Pharmarise Holdings and its competitors. Pharmarise Holdings's current PE Ratio is 50.99, which is 129% above median its own 10-year median of 22.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmarise Holdings stock overvalued right now?
Based on GuruFocus' analysis, Pharmarise Holdings (TSE:2796) is currently considered Modestly Undervalued. The stock's GF Value™ is 円608.01, compared to a current price of 円491.00 — trading 19.2% below its estimated fair value. The current PE Ratio is 50.99, which is 129% above median its 10-year median of 22.29. Pharmarise Holdings' overall GF Score™ is 50/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio calculated?
PE Ratio is calculated from a company's financial statements. For Pharmarise Holdings (TSE:2796), the current PE Ratio is 50.99 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pharmarise Holdings (TSE:2796) Overvalued in 2026?

Based on GuruFocus' analysis, Pharmarise Holdings stock appears to be undervalued. The current stock price of 円491.00 is trading 19.2% below its estimated GF Value™ of 円608.01. GuruFocus considers Pharmarise Holdings to be Modestly Undervalued.

Key valuation signals for TSE:2796:

  • PE Ratio: 50.99 (129% above median its 10-year median of 22.29)
  • GF Value™: 円608.01 vs. price of 円491.00 (19.2% below fair value)
  • GF Score™: 50/100 with 10 warning signs

No single metric tells the full story. See the TSE:2796 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pharmarise Holdings Business Description

Address 8 Floor, Sumitomo Nakano Sakue Building, 1-38-1 Chuo, Nakano-ku, Tokyo, JPN, 164-0011
Pharmarise Holdings Corp is engaged in the operation of dispensing pharmacies, which prescribe medicines to general patients based on the prescriptions issued by medical institutions. It is also engaged in the storage and management of medical examination records of patients on behalf of the medical institution.
50GF Score

Get the complete analysis for TSE:2796

PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円491.00
Price
円608.01
GF Value